TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29563633

Group type: EXPERIMENTAL
Intervention: Diabetic fasting blood glucose level
Number of subjects: 17860

Group type: COMPARATOR
Intervention: Antidiabetic drug use
Number of subjects: 17860

Group type: COMPARATOR
Intervention: Normoglycaemic men
Number of subjects: 17860
Study: 27066804

Group type: EXPERIMENTAL
Intervention: Patient-driven titration tools for mealtime insulin
Number of subjects: 0
Study: 25426637

Group type: EXPERIMENTAL
Intervention: Acupuncture plus usual care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counselling plus usual care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Counselling versus usual care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 23713218

Group type: EXPERIMENTAL
Intervention: Nongravity dependent flywheel device (RAD)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Commercially available rowing ergometer (C2)
Number of subjects: 8
Study: 20624802

Group type: EXPERIMENTAL
Intervention: Office-based educational intervention for parents to wean children from the bottle over 1 week
Number of subjects: 251

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 251
Study: 18546240

Group type: EXPERIMENTAL
Intervention: Exercise interventions
Number of subjects: 2201
Study: 16641218

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 12632354

Group type: EXPERIMENTAL
Intervention: Caudal analgesia (0.25% bupivicaine, 1 mL/kg)
Number of subjects: 46
Study: 10756410

Group type: COMPARATOR
Intervention: Topiramate (TPM)
Number of subjects: 0
Study: 8973788

Group type: EXPERIMENTAL
Intervention: Manidipine 10 mg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Manidipine 20 mg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Manidipine 40 mg
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 1426204

Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (no premedication)
Number of subjects: 9
Study: 31028598

Group type: EXPERIMENTAL
Intervention: ADAPT intervention
Number of subjects: 111

Group type: COMPARATOR
Intervention: No access to ADAPT intervention
Number of subjects: 111
Study: 28934781

Group type: EXPERIMENTAL
Intervention: Lateral decubitus position (Group L)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Prone position (Group P)
Number of subjects: 68
Study: 26070123

Group type: EXPERIMENTAL
Intervention: Induction of labor in women with GH or mild PE at term
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Antepartum predictors
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Intrapartum predictors
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Predictive models
Number of subjects: 756
Study: 24107763

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for PTSD, 8 once-weekly sessions
Number of subjects: 13
Study: 21317177

Group type: EXPERIMENTAL
Intervention: PF-00547,659 (0.03-10 mg/kg IV/SC, single or multiple doses at 4-week intervals)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 19429529

Group type: EXPERIMENTAL
Intervention: Incremental exercise tests under normoxic conditions
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Incremental exercise tests under hypoxic conditions
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Canonical correlation analysis (CCA)
Number of subjects: 23
Study: 17901847

Group type: EXPERIMENTAL
Intervention: Planecta SC(R) (PNSC)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Conventional three-way stopcock
Number of subjects: 162
Study: 15801579

Group type: EXPERIMENTAL
Intervention: Told Nicotine
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Told No Nicotine
Number of subjects: 49

Group type: COMPARATOR
Intervention: No Spray
Number of subjects: 49
Study: 11786865

Group type: EXPERIMENTAL
Intervention: Bionator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Headgear
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 0
Study: 9538963

Group type: EXPERIMENTAL
Intervention: Monounsaturated fatty acid (MUFA)‐enriched weight‐reducing formula diet
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low‐fat, high‐CHO weight‐reducing formula diet
Number of subjects: 17
Study: 8080348

Group type: EXPERIMENTAL
Intervention: Yohimbine hydrochloride, 0.4 mg/kg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 2686740

Group type: EXPERIMENTAL
Intervention: 5 micrograms PGE1
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 10 micrograms PGE1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20

Group type: COMPARATOR
Intervention: Preservative
Number of subjects: 20
Study: 17894080

Group type: EXPERIMENTAL
Intervention: Intramuscular haloperidol 5 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intramuscular haloperidol 2 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intramuscular haloperidol 1 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Chlorpromazine 25 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31142530

Group type: EXPERIMENTAL
Intervention: Auricular points acupressure (AA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham auricular points acupressure (sham AA)
Number of subjects: 60
Study: 28839339

Group type: EXPERIMENTAL
Intervention: Valbenazine (VBZ) 1, 2, 5, or 12.5 mg (Cohort 1) and 12.5, 25, 50, or 75 mg (Cohort 2) single doses
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Valbenazine (VBZ) 75, 100, 125 or 150 mg single doses
Number of subjects: 32

Group type: COMPARATOR
Intervention: Valbenazine (VBZ) 50 or 100 mg once-daily for 8 days (Cohort 1)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Valbenazine (VBZ) 50 mg once-daily for 8 days (Cohort 2)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 32
Study: 25355620

Group type: EXPERIMENTAL
Intervention: Home visits with calls
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Calls only
Number of subjects: 610
Study: 23876867

Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT) with verteporfin
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (3 monthly injections)
Number of subjects: 93
Study: 21651392

Group type: EXPERIMENTAL
Intervention: Immediate IUD insertion
Number of subjects: 575

Group type: COMPARATOR
Intervention: Delayed IUD insertion
Number of subjects: 575

Group type: COMPARATOR
Intervention: Control group (Delayed insertion)
Number of subjects: 575
Study: 19512871

Group type: EXPERIMENTAL
Intervention: AirTraq Laryngoscope
Number of subjects: 24

Group type: COMPARATOR
Intervention: Macintosh Laryngoscope
Number of subjects: 24
Study: 17350367

Group type: EXPERIMENTAL
Intervention: Age <60 years
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Age 60 to 75 years
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Age ≥75 years
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Older age (per 10-U change)
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Higher heart rate (per 10-U change)
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Lower systolic blood pressure (per 10-U change)
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure >80 mm Hg in elderly patients
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure ≤80 mm Hg and heart rate >100 beats/min
Number of subjects: 761
Study: 15488870

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10mg/day (A)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Estradiol 2mg/day (E)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: E + Atorvastatin (E + A)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: E + Norethisterone (E + P)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: E + P + A
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: E + A
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: E
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: A
Number of subjects: 94
Study: 11673867

Group type: EXPERIMENTAL
Intervention: NADPH oxidase activation in wild-type mice
Number of subjects: 0

Group type: COMPARATOR
Intervention: NADPH oxidase deficient mice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sepsis patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous injection of o,o'-[(14)C]dityrosine into mice
Number of subjects: 0
Study: 9476272

Group type: EXPERIMENTAL
Intervention: Avocado/soybean unsaponifiables
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study: 7884017

Group type: EXPERIMENTAL
Intervention: Intramuscular zuclopenthixol acetate (50 to 150 mg every 3 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Liquid oral haloperidol (10 to 30 mg daily, three times a day)
Number of subjects: 40
Study: 3279235

Group type: EXPERIMENTAL
Intervention: Unna's boots (UB)
Number of subjects: 69

Group type: COMPARATOR
Intervention: hydroactive dressing (HD)
Number of subjects: 69
Study: 31843270

Group type: EXPERIMENTAL
Intervention: Strep A vaccine (StreptAnova™), administered intramuscularly at 0, 30, and 180 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Alum-based comparator (control group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Strep A vaccine (StreptAnova™)
Number of subjects: 36
Study: 25886746

Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Parecoxib
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 23930573

Group type: EXPERIMENTAL
Intervention: Phosphate monomer containing resin (Panavia 21 TC; N = 16)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Adhesive bonding system with a phosphoric acid acrylate primer (Multilink‐Automix with Metal/Zirconia primer; N = 14)
Number of subjects: 30
Study: 21279976

Group type: EXPERIMENTAL
Intervention: Intravenous pentoxifylline
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pulse steroid and cyclophosphamide therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (20 subjects)
Number of subjects: 30
Study: 19959695

Group type: EXPERIMENTAL
Intervention: Nurse-managed, lay-led tobacco cessation intervention with nicotine replacement and behavioral counseling
Number of subjects: 302

Group type: COMPARATOR
Intervention: Personalized letter from clinic physician advising to quit smoking
Number of subjects: 302
Study: 17680469

Group type: EXPERIMENTAL
Intervention: LACE training (four-week adaptive auditory training and aural rehabilitation program)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LACE training
Number of subjects: 0
Study: 15792759

Group type: EXPERIMENTAL
Intervention: Fibrin glue (Hemaseel APR)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control (drain placement)
Number of subjects: 82
Study: 12137179

Group type: EXPERIMENTAL
Intervention: Bowling harness
Number of subjects: 33

Group type: COMPARATOR
Intervention: Non-harness group
Number of subjects: 33
Study: 10436756

Group type: EXPERIMENTAL
Intervention: SonoVue 0.3 ml
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SonoVue 0.6 ml
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SonoVue 1.2 ml
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SonoVue 2.4 ml
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SonoVue (all doses)
Number of subjects: 12
Study: 7763040

Group type: EXPERIMENTAL
Intervention: Elective lymph node dissection (ELND)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed dissection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patients who decline ELND
Number of subjects: 0
Study: 2265300

Group type: EXPERIMENTAL
Intervention: ITC hearing aids
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: ITE hearing aids
Number of subjects: 244

Group type: COMPARATOR
Intervention: BTE hearing aids
Number of subjects: 244
Study: 7372822

Group type: EXPERIMENTAL
Intervention: Hypnotic treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Biofeedback treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Trophotropic treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 31216846

Group type: EXPERIMENTAL
Intervention: PIEB 10 ml every 60 min (Group 10q60)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: PIEB 5 ml every 30 min (Group 5q30)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Continuous epidural infusion (CEI) 10 ml/h
Number of subjects: 150
Study: 28694268

Group type: EXPERIMENTAL
Intervention: Chlamydia testing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlamydia incidence
Number of subjects: 0
Study: 26088268

Group type: EXPERIMENTAL
Intervention: Idarucizumab 1 g
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Idarucizumab 2 g
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Idarucizumab 4 g
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Idarucizumab 5 g plus 2.5 g
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 23104146

Group type: EXPERIMENTAL
Intervention: Intravenous ondansetron 8 mg
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 118
Study: 21606305

Group type: EXPERIMENTAL
Intervention: Hydroxyurea therapy (part of the BABY HUG trial)
Number of subjects: 203
Study: 19114574

Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 165

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 165
Study: 17020438

Group type: EXPERIMENTAL
Intervention: Pregabalin (150-600 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0
Study: 14595564

Group type: EXPERIMENTAL
Intervention: Posture change from supine to seated
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exercise at 70% maximum oxygen uptake
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 30
Study: 11468198

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 131

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 131
Study: 11479983

Group type: EXPERIMENTAL
Intervention: Dentifrice containing 0.3% triclosan and 2.0% PVM/MA copolymer in a 0.243% sodium fluoride/silica base
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control dentifrice (0.243% sodium fluoride silica base)
Number of subjects: 153
Study: 7685442

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Losartan 100 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Losartan > 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2444780

Group type: EXPERIMENTAL
Intervention: Nifedipine (mean dose, 70 mg/day)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nitroglycerin patches (mean dose, 16 cm/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control period (no other antianginal treatment)
Number of subjects: 15
Study: 29764853

Group type: EXPERIMENTAL
Intervention: CC-486 monotherapy (300 mg, every day, days 1-14/21)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: CC-486 in combination with carboplatin (300 mg, every day, days 1-14/21)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: CC-486 in combination with nab-paclitaxel (200 mg, every day, days 1-14/21)
Number of subjects: 169

Group type: COMPARATOR
Intervention: CC-486 (various doses)
Number of subjects: 169
Study: 26915749

Group type: EXPERIMENTAL
Intervention: Tolvaptan (n=108)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Conventional treatment (n=109)
Number of subjects: 217
Study: 25129664

Group type: EXPERIMENTAL
Intervention: everolimus-eluting stent
Number of subjects: 140
Study: 23041961

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training before high-intensity resistance training (BLRT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training after high-intensity resistance training (ALRT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training before high-intensity resistance training (BLRT) and Low-intensity resistance training after high-intensity resistance training (ALRT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 30
Study: 21592681

Group type: EXPERIMENTAL
Intervention: Sertraline (100mg daily)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 19591337

Group type: EXPERIMENTAL
Intervention: 0.05% cetylpyridinium chloride (CPC) mouthrinse
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control mouthrinse without 0.05% CPC
Number of subjects: 43
Study: 16822077

Group type: EXPERIMENTAL
Intervention: Artificial tears applied in patients with dry-eye syndrome or contact lenses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy eyes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dry-eye syndrome
Number of subjects: 0

Group type: COMPARATOR
Intervention: Contact lenses
Number of subjects: 0
Study: 12757574

Group type: EXPERIMENTAL
Intervention: Enhanced balance training for 6 weeks consisting of repetitive tasks of increasing difficulty specific to functional balance.
Number of subjects: 199

Group type: COMPARATOR
Intervention: Control group received physiotherapy conforming to existing practice in elderly patients with mobility problems.
Number of subjects: 199
Study: 10906618

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 0
Study: 9262265

Group type: EXPERIMENTAL
Intervention: Bolus injection of FSH (450 IU i.m.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8365747

Group type: EXPERIMENTAL
Intervention: 1.5 x 10(6) units of streptokinase (SK) in 200 ml of normal saline
Number of subjects: 100

Group type: COMPARATOR
Intervention: 200 ml of normal saline alone (control)
Number of subjects: 100
Study: 3060889

Group type: EXPERIMENTAL
Intervention: Clonidine (CLON) 1.5 micrograms/kg IV
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Clonidine (CLON) 2.0 micrograms/kg IV
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Clonidine (CLON) 2.0 micrograms/kg IV (repeated tests)
Number of subjects: 22
Study: 30968559

Group type: EXPERIMENTAL
Intervention: Absorb bioresorbable vascular scaffold (BVS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Xience everolimus eluting stent (EES)
Number of subjects: 0
Study: 28914732

Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Family/friend social support for healthy eating
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Social problems
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Physical comfort and family relations WRQOL
Number of subjects: 360
Study: 27595715

Group type: EXPERIMENTAL
Intervention: Single-session root canal treatment (GSS)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Two-session root canal treatment with calcium hydroxide intracanal medication (GTS)
Number of subjects: 26
Study: 25531935

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 681

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 681
Study: 23013624

Group type: EXPERIMENTAL
Intervention: H. pylori-positive group (n=95)
Number of subjects: 174

Group type: COMPARATOR
Intervention: H. pylori-negative group (n=79)
Number of subjects: 174
Study: 20628004

Group type: EXPERIMENTAL
Intervention: Green tea (6 cups daily for 3 to 6 weeks)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Water (control group)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: EGCG incubation with LNCaP prostate cancer cells
Number of subjects: 17
Study: 18173402

Group type: EXPERIMENTAL
Intervention: Nanocrystalline hydroxyapatite (NHA)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Natural bone mineral in combination with a collagen membrane (NBM+CM)
Number of subjects: 22
Study: 16595780

Group type: EXPERIMENTAL
Intervention: Low-dose isotretinoin (30 mg/day)
Number of subjects: 1190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1190

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 1190
Study: 12560950

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 29

Group type: COMPARATOR
Intervention: Men
Number of subjects: 29
Study: 10546924

Group type: EXPERIMENTAL
Intervention: Mibefradil
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 8735992

Group type: COMPARATOR
Intervention: Blocked practice
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Random practice
Number of subjects: 64
Study: 1659474

Group type: EXPERIMENTAL
Intervention: Computed tomography (CT)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: SPECT 99Tcm (V) DMSA
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Combined imaging with CT
Number of subjects: 25

Group type: COMPARATOR
Intervention: CT
Number of subjects: 25
Study: 7171415

Group type: EXPERIMENTAL
Intervention: Methadone 10 mg i.v. (acute administration)
Number of subjects: 26
Study: 31894444

Group type: EXPERIMENTAL
Intervention: Home-based intervention including health education, relationship-building skills, and Couples HIV Testing and Counseling
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Home-based intervention
Number of subjects: 96
Study: 31253425

Group type: EXPERIMENTAL
Intervention: Modified fitting guide
Number of subjects: 183

Group type: COMPARATOR
Intervention: Previous fitting guide
Number of subjects: 183
Study: 28146065

Group type: EXPERIMENTAL
Intervention: PolyGlycopleX® (PGX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psyllium (PSY)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (rice flour)
Number of subjects: 0
Study: 25849254

Group type: EXPERIMENTAL
Intervention: Primary tumor resection followed by systemic chemotherapy
Number of subjects: 290

Group type: COMPARATOR
Intervention: Systemic chemotherapy alone
Number of subjects: 290
Study: 24021606

Group type: EXPERIMENTAL
Intervention: One specific physical treatment device using a biorhythmically defined stimulus for vasomotion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two other physical treatment devices
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three other physical treatment devices
Number of subjects: 0